Mesenchymal Cells are a versatile and multipotent type of stem cell found in various tissues throughout the body, primarily in the embryonic mesoderm and adult connective tissues. These cells play a crucial role in tissue development, repair, and regeneration. Mesenchymal stem cells (MSCs) are characterized by their ability to differentiate into multiple cell types, including bone, cartilage, adipose tissue, and muscle cells. MSCs exhibit immunomodulatory properties, influencing the immune response and reducing inflammation, making them promising candidates for regenerative medicine and cell-based therapies. In addition to their regenerative potential, mesenchymal cells contribute to tissue homeostasis by secreting bioactive molecules that support cell survival, proliferation, and tissue repair. The regenerative capacity and immunomodulatory features of mesenchymal cells make them valuable in treating various conditions, including musculoskeletal disorders, autoimmune diseases, and injuries. However, research continues to explore the precise mechanisms underlying their functions, standardizing isolation and culture techniques, and addressing challenges to optimize their therapeutic applications. The field of mesenchymal cell biology holds great promise for advancing regenerative medicine and developing innovative treatments for a range of medical conditions.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States